The Data Gap in Cardiovascular Monitoring: What You Need to Know

Executive Summary: Cardiovascular monitoring technology has advanced significantly, offering powerful tools for early detection and ongoing care. However, a critical behavior gap persists: while many patients track their heart health, few share that data with their physicians. Closing this gap through continuous monitoring and improved patient-provider communication is essential to reduce cardiovascular mortality and leverage new reimbursement opportunities.

Cardiovascular disease (CVD) remains a critical public health crisis. According to the CDC (October 2024), one person dies every 34 seconds from CVD in the United States — and in 2023 alone, 919,032 Americans died from CVD, representing one in every three deaths.

Cardiovascular monitoring technology encompasses devices, systems, and AI-powered tools used to track, record, and analyze heart function, ranging from hospital-grade ECG machines to consumer smartwatches. This market is expanding rapidly. According to Global Market Insights (March 2026), the global cardiac monitoring devices market was valued at $15 billion in 2025 and is projected to reach $29 billion by 2035. The AI-powered segment is growing even faster — from $1.82 billion today to nearly $20 billion by 2035, representing a 27% CAGR, per InsightAce Analytic (February 2026).

Despite these advances, a significant disconnect exists. A national survey commissioned by The Ohio State University Wexner Medical Center (January 2025) found that nearly two-thirds of Americans regularly use a device to monitor their heart health, yet only 25% share that data with their clinician. As Dr. Laxmi Mehta, MD, FACC, FAHA, Section Director of Preventive Cardiology and Women’s Cardiovascular Health at Ohio State’s Wexner Medical Center, notes: “These self-monitoring devices are really helpful to patients and their health care providers because they can potentially catch things early.” A device that never undergoes clinical review, however, catches nothing. The technology is working; the behavior is not.

This data gap is particularly consequential in high-risk regions. The Alabama Department of Public Health confirms the state sits inside the CDC-designated Stroke Belt, where age-adjusted stroke mortality exceeds the national rate by 34%. University of Alabama at Birmingham researchers, publishing in Mayo Clinic Proceedings, found cardiovascular mortality in the Stroke Belt runs 16% higher than the rest of the country — and closing that gap would require preventing more than 100,000 additional deaths.

Key Strategies and Best Practices

Close the Data Loop Between Patients and Providers. Wearable heart data that never leaves a device is a wasted clinical asset. Patients should proactively download and share ECG summaries, heart rate trend reports, and irregular rhythm alerts before every cardiology or primary care appointment.

Understand Expanded Insurance Coverage. Reimbursement rules changed dramatically on January 1, 2026. According to a McDonald Hopkins analysis of the CMS 2026 Physician Fee Schedule Final Rule, remote cardiac monitoring data transmitted for just 2–15 days in a 30-day period is now billable — down from the previous 16-day minimum. This shift makes remote monitoring programs financially viable for practices that previously could not sustain them. As of May 2026, remote patient monitoring is covered by 42 state Medicaid programs, according to the Center for Connected Health Policy (via Prevounce).

Prioritize Continuous Monitoring Over Snapshot Testing. A single in-office ECG captures roughly 10 seconds of cardiac activity. Long-term continuous monitoring catches what a snapshot misses. iRhythm’s AVALON real-world study, presented at the Heart Rhythm Society’s 2025 conference, demonstrated that the Zio 14-day continuous patch produced higher diagnostic yield and lower rates of repeat testing compared to every competing long-term cardiac monitor. Additionally, per the American College of Cardiology (November 2025), cardiac rehabilitation services were permanently added to the Medicare telehealth list beginning in 2026, expanding the infrastructure for longitudinal heart care outside hospital settings.

Match the Technology to the Clinical Question. Not every patient needs a 14-day patch monitor, and not every concern warrants a hospital visit. The appropriate tool depends on the specific clinical question — whether intermittent palpitations or post-procedure surveillance. Ask your care team to explain the monitoring plan, not just hand you a device.

Common Mistakes to Avoid

Collecting data without acting on it. Treating cardiac monitoring like a fitness tracker — generating data but never sharing it with a clinician — is a critical failure. The device alone is not the intervention; the clinical conversation is.

Equating consumer wearables with medical-grade devices. They are not equivalent. AliveCor’s Kardia 12L received expanded FDA clearance in January 2026 for 39 cardiac determinations and has identified over 4,000 cases of myocardial infarction and ischemia across more than 250 U.S. clinical practices since its June 2024 launch, according to HLTH.com. Consumer smartwatches cannot replicate this diagnostic depth.

Waiting for symptoms. Cardiac arrhythmias and ischemic events frequently present without warning. This is precisely the clinical case made by iRhythm’s AVALON study at the Heart Rhythm Society 2025 conference — continuous, uninterrupted 14-day monitoring delivers superior diagnostic yield over isolated spot-checks.

How to Get Started

Step 1 — Start With Existing Data. If you use a smartwatch or blood pressure cuff, print or export the last 30 days of heart rate, rhythm, or blood pressure data and bring it to your next appointment as a conversation starter.

Step 2 — Ask About Remote Monitoring. With the updated CMS 2026 Physician Fee Schedule requiring only 2–15 days of data transmission, ask your provider whether they offer a remote patient monitoring program. If they do not, that is useful information too.

Step 3 — Understand Clinical-Grade Options. Consumer wearables are a starting point, not a finish line. When structured monitoring is recommended, evidence points toward continuous, patch-based systems for optimal diagnostic yield. Home-based cardiac monitoring is the fastest-growing sector in this space — Mordor Intelligence projects a 7.11% CAGR through 2030.

Conclusion

Cardiovascular monitoring technology is advancing rapidly. AI is entering clinical cardiology workflows now. CMS has lowered billing thresholds for remote monitoring. Devices like AliveCor’s Kardia 12L are detecting 39 cardiac conditions from a handheld device. The American Heart Association projects CVD will affect 61% of the U.S. population by 2050, driving health systems toward continuous monitoring to contain an estimated $422.3 billion in annual treatment costs, per Mordor Intelligence.

The infrastructure is ready. What changes outcomes is early detection, consistent monitoring, and closing the gap between the data patients collect and the care providers can deliver. Perfect Rhythm is the partner built for exactly this moment — contact us to learn how our cardiovascular monitoring solutions can serve your practice or your patients.

Frequently Asked Questions

What is cardiovascular monitoring technology? It refers to devices and systems that track heart function — including heart rate, rhythm, electrical activity, and blood pressure — either continuously or intermittently. This includes hospital-based ECG systems, wearable patches (e.g., iRhythm Zio), consumer smartwatches, and AI-powered diagnostic platforms.

How accurate is AI-powered cardiac monitoring? Accuracy varies by platform. AliveCor’s Kardia 12L has FDA clearance for 39 cardiac determinations and reduced ECG acquisition time by 29% compared to conventional systems in a peer-reviewed study. Mass General Brigham’s ECG2Stroke model predicts stroke risk up to 10 years out from a single 10-second ECG, performing comparably to validated clinical risk scores.

Is remote cardiac monitoring covered by insurance? Yes. CMS updated its Physician Fee Schedule effective January 1, 2026, making remote patient monitoring billable after just 2–15 days of data transmission in a 30-day period. As of May 2026, 42 state Medicaid programs also cover these services.

Why is cardiovascular monitoring especially important in the Stroke Belt? The CDC-designated Stroke Belt experiences stroke mortality 34% above the national average. UAB researchers publishing in Mayo Clinic Proceedings found cardiovascular mortality in the region runs 16% higher than the national rate — making early, continuous monitoring a clinical imperative, not an option.

Can I use my smartwatch data for cardiac care? Yes, but only if it reaches a clinician. The Ohio State Wexner Medical Center survey found only 1 in 4 people who track heart data with a wearable actually share it with their doctor. Closing that loop is the single highest-leverage action a patient can take.